Beacon Biosignals

About Beacon Biosignals

Beacon Biosignals is dedicated to advancing brain health through AI-driven neurotechnology. Their mission is to bring precision neuroscience to clinical trials, accelerating drug development for neurological and psychiatric conditions to deliver life-changing treatments to patients faster.

Products & Services

Waveband:An FDA-cleared headband for high-fidelity sleep EEG capture at home or in clinical settings.

Datastore:A component of their platform for managing EEG data.

Beacon HQ:Analytics software for monitoring compliance and treatment responses in clinical trials.

Clinical Study Operations:Full-service support for device setup, software integration, and data quality in clinical trials.

Scientific Services:Expertise in reporting and scientific support across drug development stages.

Beacon Platform:An end-to-end solution for EEG biomarkers in clinical research, integrating AI models trained on extensive EEG data to characterize brain function.

Specialties

AI-Driven Neurotechnology Precision Neuroscience EEG Biomarkers Sleep Analysis Clinical Trial Optimization Drug Development for Neurological and Psychiatric Conditions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 86000000 MR: - FA: 86 million FAN: 86000000	D: 2025-11-13 FD: 2025-11-13	10 investors

Series B Latest

2025-11-13

$86.0M

10 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jacob Donoghue

CEO & Co-Founder

J

Jarrett Revels

CTO & Co-Founder

M

Matt Alkaitis

Chief Clinical Officer

D

David Matthews

Chief Business Officer

A

Alex Chan

VP of Analytics and Machine Learning

E

Emily Mitchell

VP of Clinical Study Operations Service

View 9 more team members with Pro

Unlock Full Team Directory

Recent News